| pubmed-article:8577216 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8577216 | lifeskim:mentions | umls-concept:C0596545 | lld:lifeskim |
| pubmed-article:8577216 | lifeskim:mentions | umls-concept:C0339897 | lld:lifeskim |
| pubmed-article:8577216 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:8577216 | lifeskim:mentions | umls-concept:C1710425 | lld:lifeskim |
| pubmed-article:8577216 | lifeskim:mentions | umls-concept:C0205265 | lld:lifeskim |
| pubmed-article:8577216 | lifeskim:mentions | umls-concept:C1512948 | lld:lifeskim |
| pubmed-article:8577216 | lifeskim:mentions | umls-concept:C1555582 | lld:lifeskim |
| pubmed-article:8577216 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:8577216 | pubmed:dateCreated | 1996-3-13 | lld:pubmed |
| pubmed-article:8577216 | pubmed:abstractText | 15 patients with predominantly alcoholtoxic liver cirrhosis (mean age 50 years; 8 men and 7 women) were treated by the technically successful implantation of a transjugular portosystemic stent-shunt (TIPS) within a period of 1 year. The indications for TIPS implantation were the following: gastroesophageal bleedings in 12 cases (10 patients with recurrent variceal bleeding including 2 emergency cases with severe bleeding resistant to conventional therapy and 2 patients with exclusively gastral bleeding due to severe hypertensive gastropathy) and ascites resistant to conventional therapy in 3 cases. Portovenous pressure could be effectively reduced by mean of 37%. Within a mean observation period of 8 months 13 patients including the emergency cases remained without recurrent bleeding. Duplexsonography showed patent stents. 1 patient suffered from an early recurrent bleeding due to occlusion of the stent-shunt. The estimation of liver function according to the Child-Pugh-classification showed only minor changes. Before TIPS 9 patients were in class A, 4 in B, 2 in C; after TIPS 8 patients in A, 5 in B and 2 in C. Ascites resolved completely. Following TIPS all patients appeared to abstain from alcohol. After TIPS 5 from 14 surviving patients (36%) developed clinically manifest encephalopathy within the first 4-8 weeks (2 patients with previous episodes of encephalopathy, 2 other patients after withdrawal of lactulose). By enhanced conservative treatment (lactulose, paromomycine and protein restriction) encephalopathy could be overcome. 8 from 11 surviving patients investigated displayed characteristic MRI changes with an increased signal intensity in the basal ganglia (T1 weighted images). According to our preliminary results TIPS represents a new successful interventional regimen for the treatment of portal hypertension in selected cases. | lld:pubmed |
| pubmed-article:8577216 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8577216 | pubmed:language | ger | lld:pubmed |
| pubmed-article:8577216 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8577216 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8577216 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8577216 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:8577216 | pubmed:issn | 0300-8622 | lld:pubmed |
| pubmed-article:8577216 | pubmed:author | pubmed-author:PetersKK | lld:pubmed |
| pubmed-article:8577216 | pubmed:author | pubmed-author:HartmannHH | lld:pubmed |
| pubmed-article:8577216 | pubmed:author | pubmed-author:FigullaH RHR | lld:pubmed |
| pubmed-article:8577216 | pubmed:author | pubmed-author:ThielAA | lld:pubmed |
| pubmed-article:8577216 | pubmed:author | pubmed-author:RamadoriGG | lld:pubmed |
| pubmed-article:8577216 | pubmed:author | pubmed-author:KunertH JHJ | lld:pubmed |
| pubmed-article:8577216 | pubmed:author | pubmed-author:NolteWW | lld:pubmed |
| pubmed-article:8577216 | pubmed:author | pubmed-author:WiltfangJ GJG | lld:pubmed |
| pubmed-article:8577216 | pubmed:author | pubmed-author:GeeseKK | lld:pubmed |
| pubmed-article:8577216 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8577216 | pubmed:volume | 25 | lld:pubmed |
| pubmed-article:8577216 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8577216 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8577216 | pubmed:pagination | 264-6, 269-70 | lld:pubmed |
| pubmed-article:8577216 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:meshHeading | pubmed-meshheading:8577216-... | lld:pubmed |
| pubmed-article:8577216 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:8577216 | pubmed:articleTitle | [Initial clinical experiences with TIPS (transjugular intrahepatic portasystemic stent-shunt)]. | lld:pubmed |
| pubmed-article:8577216 | pubmed:affiliation | Medizinische Klinik, Georg-August-Universität, Göttingen. | lld:pubmed |
| pubmed-article:8577216 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8577216 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:8577216 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8577216 | lld:pubmed |
